Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer
Year: 2021
Type: review
Source: Clinical Cancer Research
Authors: Theodore W. Laetsch, David S. Hong
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bayer
OpenAlex ID: W3152991128
